Funding Opportunities & Notices Search Results
    

Related Links:                        
All Active Funding Opportunities (RFAs & PAs)

            

       Matching Records:  1274        Sorted by:  Issuing Organization then Release Date *

Announcement
Number
Related
Announc.

Issuing
Organization
*
Release
Date
Opening Date
(SF424 Only) Opening Date is the earliest date an electronic application may be submitted to Grants.gov - Applies only to SF424 electronic applications. Click on Question Mark for more information.
Expiration
Date
Activity
Code(s)
Title
RFA-HS-18-002 See Related AHRQ 09/13/2018 12/04/2018 01/18/2019 R18 Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18)
PA-18-794 See Related AHRQ 05/21/2018 09/17/2018 07/06/2021 R03 AHRQ Small Research Grant Program (R03)
PA-18-793 See Related AHRQ 05/21/2018 08/24/2018 01/28/2021 R18 AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
PA-18-795 See Related AHRQ 05/21/2018 09/05/2018 07/06/2021 R01 AHRQ Health Services Research Projects (R01)
PA-18-792 See Related AHRQ 05/21/2018 08/28/2018 01/28/2020 U18 Advancing Evidence into Practice through Shared, Interoperable Clinical Decision Support Resources (U18)
PA-18-765 See Related AHRQ 05/02/2018 07/30/2018 05/02/2023 R36 AHRQ Health Services Research Dissertation Program (R36)
PA-18-750 See Related AHRQ 04/10/2018 09/25/2018 09/08/2021 R18 Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18)
PA-17-481 See Related AHRQ 09/12/2017 09/12/2017 08/09/2022 F32 Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32)
PA-17-261 See Related AHRQ 04/20/2017 08/25/2017 01/26/2019 R18 Developing New Clinical Decision Support to Disseminate and Implement Evidence-Based Research Findings (R18)
PA-17-260 See Related AHRQ 04/20/2017 08/25/2017 01/26/2019 R18 Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Evidence-Based Research Findings (R18)
PA-17-246 See Related AHRQ 04/03/2017 04/17/2017 07/17/2019 R21 Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)
PA-17-247 See Related AHRQ 04/03/2017 04/17/2017 09/26/2019 U18 Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
PA-17-232 See Related AHRQ 03/29/2017 03/31/2017 07/13/2022 K08 AHRQ Mentored Clinical Scientist Research Career Development Award (K08)
PA-17-077 See Related AHRQ 12/12/2016 01/25/2017 01/26/2020 R18 Utilizing Health Information Technology to Scale and Spread Successful Practice Models Using Patient-reported Outcomes (R18)
PA-17-007 See Related AHRQ 10/13/2016 12/25/2016 01/26/2021 R18 Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
PA-17-008 See Related AHRQ 10/13/2016 01/05/2017 03/06/2021 R01 Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
PA-16-453 See Related AHRQ 09/29/2016 11/02/2016 11/02/2021 R13 AHRQ Conference Grant Programs (R13)
PA-16-424 See Related AHRQ 09/08/2016 01/05/2017 02/05/2022 R01 Developing Measures of Shared Decision Making (R01)
PA-16-423 See Related AHRQ 09/06/2016 11/01/2016 10/31/2021 R01 Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
PA-16-422 See Related AHRQ 09/06/2016 11/01/2016 10/31/2021 R18 Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
PA-16-421 See Related AHRQ 09/06/2016 12/25/2016 09/26/2019 R18 Advancing Patient Safety Implementation through Safe Medication Use Research (R18)
PA-16-420 See Related AHRQ 09/06/2016 11/25/2016 01/26/2022 R18 Advances in Patient Safety through Simulation Research (R18)
PA-16-223 See Related AHRQ 05/05/2016 09/12/2016 11/12/2019 K01 AHRQ Mentored Research Scientist Research Career Development Award (K01)
PA-15-180 See Related AHRQ 04/08/2015 09/05/2015 11/06/2020 R01 Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01)
PA-15-179 See Related AHRQ 04/08/2015 08/25/2015 09/27/2020 R18 Understanding and Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18)
PAR-18-812 See Related CDC 05/30/2018 05/25/2018 11/18/2023 R01 Occupational Safety and Health Research (R01)
PAR-18-799 See Related CDC 05/24/2018 05/24/2018 11/18/2023 K01 K01 Mentored Research Scientist Development Award
PAR-18-797 See Related CDC 05/24/2018 05/24/2018 11/18/2023 R03 NIOSH Small Research Grant Program
PAR-15-303 See Related CDC 07/21/2015 n/a 10/21/2019 T42 Occupational Safety and Health Education and Research Centers (T42)
PAR-18-827 See Related FDA 06/11/2018 06/27/2018 01/16/2021 R01 Minor Use Minor Species Development of Drugs (R01)
PAR-18-604 See Related FDA 01/29/2018 02/01/2018 09/02/2023 U18 Vet-LIRN Network Capacity-Building Projects
RFA-FD-18-001 See Related FDA 10/31/2017 11/06/2017 12/02/2021 U18 Flexible Funding Model - Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18)
PAR-17-141 See Related FDA 01/27/2017 02/22/2017 02/16/2019 U18 CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18)
PAR-16-378 See Related FDA 07/27/2016 08/01/2016 10/12/2019 R13 FDA Scientific Conference Grant Program (R13)
PAR-16-137 See Related FDA 03/17/2016 05/04/2016 04/04/2019 U18 State and Territory Cooperative Agreement to Enhance Produce Safety in Preparation of Implementation of FDA's Rule: Standards for the Growing, Harvesting, Packing, & Holding of Produce for Human Consumption (U18)
PAR-16-099 See Related FDA 02/12/2016 03/01/2016 05/02/2020 U01 NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)
RFA-FD-15-022 See Related FDA 05/04/2015 05/08/2015 04/03/2019 U18 Integrated Food Defense & Emergency Response Cooperative Agreement Program IFD&ER (U18)
PAR-15-187 See Related FDA 04/17/2015 04/30/2015 05/01/2019 U01 Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01)
PAR-18-901 See Related FIC 08/13/2018 10/13/2018 11/14/2020 D43 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)(Clinical Trial Optional)
PAR-18-840 See Related FIC 06/26/2018 06/26/2018 07/26/2019 D43 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
PAR-18-835 See Related FIC 06/19/2018 10/07/2018 11/08/2019 R01 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
PAR-18-836 See Related FIC 06/19/2018 10/07/2018 11/08/2019 R21 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
PAR-18-539 See Related FIC 12/21/2017 02/07/2018 03/07/2020 K01 International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed
PAR-18-540 See Related FIC 12/21/2017 02/07/2018 03/07/2020 K01 International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required
PAR-17-097 See Related FIC 12/22/2016 02/14/2017 03/15/2019 D71 Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71)
PAR-17-058 See Related FIC 11/17/2016 06/26/2017 07/26/2019 D71 Planning Grant for Global Infectious Disease Research Training Program (D71)
PAR-17-001 See Related FIC 10/04/2016 11/14/2016 12/15/2018 K43 Emerging Global Leader Award (K43)
PAR-18-910 See Related NCATS 08/31/2018 04/03/2019 08/27/2021 U01 Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required)
PAR-18-909 See Related NCATS 08/31/2018 10/01/2018 03/05/2021 X02 Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed)
RFA-TR-18-021 See Related NCATS 06/08/2018 09/09/2018 10/10/2018 U2C Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
RFA-TR-18-020 See Related NCATS 06/08/2018 09/09/2018 10/10/2018 U54 Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional)
PAR-18-464 See Related NCATS 12/05/2017 12/25/2017 09/26/2018 U54 Clinical and Translational Science Award U54 (Clinical Trial Optional)
PAR-18-462 See Related NCATS 11/30/2017 02/16/2018 11/17/2020 U34 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed)
PAR-18-245 See Related NCATS 11/21/2017 02/27/2018 11/30/2018 R21 Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21 Clinical Trial Optional)
PAR-18-244 See Related NCATS 11/21/2017 02/06/2018 11/10/2018 U01 Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)
PAR-18-332 See Related NCATS 10/20/2017 01/05/2018 11/06/2020 U01 Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)
PAR-17-465 See Related NCATS 08/21/2017 09/30/2017 09/08/2020 UH2 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
PAR-17-035 See Related NCATS 10/27/2016 12/05/2016 09/06/2019 R43/R44 Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
PAR-17-036 See Related NCATS 10/27/2016 12/05/2016 09/06/2019 R41/R42 Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
PA-16-328 See Related NCATS 06/14/2016 06/15/2016 03/02/2019 Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)
PA-18-920 See Related NCCIH 09/12/2018 11/01/2018 12/02/2018 NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp Clinical Trial Optional)
PAR-18-828 See Related NCCIH 06/13/2018 07/31/2018 11/05/2019 R33 NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
PAR-18-829 See Related NCCIH 06/13/2018 07/31/2018 11/05/2019 R61/R33 NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
PAR-18-697 See Related NCCIH 03/05/2018 05/07/2018 11/05/2019 U24 Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
PAR-18-696 See Related NCCIH 03/05/2018 05/07/2018 11/05/2019 UG3/UH3 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
PA-18-682 See Related NCCIH 02/26/2018 03/05/2018 04/06/2019 R41/R42 Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
PAR-18-662 See Related NCCIH 02/14/2018 05/01/2018 02/29/2020 UG3/UH3 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
PAR-18-663 See Related NCCIH 02/14/2018 05/01/2018 02/29/2020 U24 Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
PA-18-607 See Related NCCIH 01/30/2018 03/05/2018 04/06/2019 R43/R44 Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed)
PAR-18-125 See Related NCCIH 11/30/2017 05/08/2018 11/05/2019 U01 NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-417 See Related NCCIH 11/29/2017 01/16/2018 09/08/2020 R34 Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 - Clinical Trials Required)
PAS-18-121 See Related NCCIH 11/28/2017 03/06/2018 01/06/2020 R41/R42 Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional)
PAS-18-120 See Related NCCIH 11/28/2017 03/06/2018 01/06/2020 R43/R44 Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional)
PAR-18-118 See Related NCCIH 11/02/2017 01/03/2018 03/01/2020 U01 NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-115 See Related NCCIH 11/02/2017 01/02/2018 06/29/2019 R33 Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required)
PAR-18-114 See Related NCCIH 11/02/2017 01/02/2018 06/29/2019 R61/R33 Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)
PAR-18-113 See Related NCCIH 10/30/2017 12/26/2017 01/08/2020 P01 Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional)
PA-18-322 See Related NCCIH 10/13/2017 01/16/2018 01/08/2021 R21 Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
PA-18-323 See Related NCCIH 10/13/2017 01/05/2018 01/08/2021 R01 Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
RFA-CA-19-002 See Related NCI 09/17/2018 01/22/2019 02/23/2019 R01 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
RFA-CA-18-029 See Related NCI 09/14/2018 10/15/2018 11/16/2018 UG1 Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
RFA-CA-18-030 See Related NCI 09/14/2018 10/15/2018 11/16/2018 U24 Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
PAR-18-919 See Related NCI 09/12/2018 01/05/2019 05/08/2020 R01 Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
RFA-CA-19-016 See Related NCI 09/11/2018 11/07/2018 12/08/2018 U54 Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
RFA-CA-19-001 See Related NCI 09/10/2018 12/09/2018 01/10/2019 U01 Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
PAR-18-913 See Related NCI 09/07/2018 01/11/2019 08/12/2021 U01 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
PAR-18-911 See Related NCI 09/05/2018 10/14/2018 11/14/2020 P20 Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
RFA-CA-18-018 See Related NCI 08/28/2018 10/15/2018 11/16/2018 U54 Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)
RFA-CA-18-028 See Related NCI 08/24/2018 12/08/2018 01/09/2019 R21 Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
RFA-CA-18-027 See Related NCI 08/24/2018 12/08/2018 01/09/2019 R01 Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
PA-18-902 See Related NCI 08/14/2018 09/05/2018 09/08/2021 R01 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
RFA-CA-19-003 See Related NCI 08/13/2018 11/01/2018 12/18/2018 U54 Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)
RFA-CA-19-004 See Related NCI 08/13/2018 11/01/2018 12/18/2018 U01 Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed)
RFA-CA-19-017 See Related NCI 08/10/2018 12/09/2018 01/10/2019 U01 Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)
RFA-CA-18-012 See Related NCI 08/09/2018 10/15/2018 11/16/2018 UM1 Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)
PAR-18-892 See Related NCI 08/07/2018 09/16/2018 09/08/2021 R21 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
PAR-18-893 See Related NCI 08/07/2018 09/05/2018 09/08/2021 R01 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
PAR-18-888 See Related NCI 08/02/2018 12/11/2018 01/12/2019 R50 NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-18-887 See Related NCI 08/02/2018 12/11/2018 01/12/2019 R50 NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-18-880 See Related NCI 07/30/2018 10/02/2018 11/03/2018 R35 NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
PAR-18-869 See Related NCI 07/24/2018 10/07/2018 03/09/2021 R01 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
PA-18-842 See Related NCI 06/28/2018 08/10/2018 09/11/2020 Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
PAR-18-841 See Related NCI 06/28/2018 10/19/2018 06/15/2021 U24 Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)
PAR-18-802 See Related NCI 05/24/2018 08/05/2018 01/06/2021 R41/R42 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)
PAR-18-801 See Related NCI 05/24/2018 08/05/2018 01/06/2021 R43/R44 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
PAR-18-767 See Related NCI 04/30/2018 12/09/2018 01/10/2020 U54 Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)
RFA-CA-18-026 See Related NCI 04/27/2018 08/19/2018 09/20/2018 R01 Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
RFA-CA-18-021 See Related NCI 04/03/2018 05/29/2018 10/31/2018 R01 Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)
RFA-CA-18-022 See Related NCI 04/03/2018 05/29/2018 10/31/2018 U01 Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)
RFA-CA-18-024 See Related NCI 04/03/2018 05/29/2018 10/31/2018 P50 Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)
RFA-CA-18-023 See Related NCI 04/03/2018 05/29/2018 10/31/2018 P01 Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)
PA-18-738 See Related NCI 04/03/2018 05/05/2018 05/08/2021 R01 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).
PA-18-739 See Related NCI 04/03/2018 05/16/2018 05/08/2021 R21 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).
PAR-18-731 See Related NCI 03/29/2018 05/19/2018 11/20/2020 R21 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
RFA-CA-18-020 See Related NCI 03/09/2018 05/29/2018 10/31/2018 R21 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
RFA-CA-18-019 See Related NCI 03/09/2018 05/29/2018 10/31/2018 R01 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
PAR-18-681 See Related NCI 02/27/2018 03/11/2018 10/12/2019 R01 Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)
PA-18-678 See Related NCI 02/23/2018 05/16/2018 05/08/2021 R21 Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
PA-18-677 See Related NCI 02/23/2018 05/05/2018 05/08/2021 R01 Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
PAR-18-674 See Related NCI 02/21/2018 05/13/2018 06/16/2020 R21 U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
PAR-18-675 See Related NCI 02/21/2018 05/13/2018 06/16/2020 R01 U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
PAR-18-655 See Related NCI 02/13/2018 05/19/2018 11/20/2020 R21 Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
PAR-18-654 See Related NCI 02/13/2018 05/19/2018 11/20/2020 R01 Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
PAR-18-641 See Related NCI 02/07/2018 04/30/2018 09/27/2019 R21 Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
PAR-18-640 See Related NCI 02/07/2018 04/30/2018 09/27/2019 R01 Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
PAR-18-639 See Related NCI 02/07/2018 05/13/2018 06/14/2019 R21 Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
PAR-18-638 See Related NCI 02/07/2018 05/13/2018 06/14/2019 R01 Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
PA-18-629 See Related NCI 02/05/2018 05/05/2018 05/08/2021 R01 Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
PAR-18-616 See Related NCI 02/01/2018 05/05/2018 07/06/2019 U01 Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)
PAR-18-605 See Related NCI 01/30/2018 03/11/2018 04/12/2019 R01 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
PAR-18-606 See Related NCI 01/30/2018 03/11/2018 04/12/2019 R21 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
PAR-18-560 See Related NCI 01/05/2018 02/15/2018 01/08/2021 R01 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)
PAR-18-559 See Related NCI 01/05/2018 02/15/2018 01/08/2021 R01 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
PAR-18-530 See Related NCI 12/21/2017 02/28/2001 01/08/2021 R01 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
PA-18-531 See Related NCI 12/20/2017 01/16/2018 01/08/2021 R03 Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
PA-18-532 See Related NCI 12/20/2017 01/16/2018 01/08/2021 R21 Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
PA-18-529 See Related NCI 12/20/2017 01/05/2018 01/08/2021 R01 Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
PA-18-493 See Related NCI 12/11/2017 05/05/2018 05/08/2021 R01 Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)
PA-18-492 See Related NCI 12/11/2017 05/16/2018 05/08/2021 R21 Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)
PAR-18-466 See Related NCI 12/06/2017 01/12/2018 03/13/2021 K22 The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)
PAR-18-467 See Related NCI 12/06/2017 01/12/2018 03/13/2021 K22 The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
PAR-18-476 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
PAR-18-477 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Courses for Skills Development (R25)
PAR-18-478 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Research Experiences (R25)
RFA-CA-18-010 See Related NCI 12/04/2017 01/28/2018 09/29/2018 P50 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)
RFA-CA-18-009 See Related NCI 12/04/2017 01/28/2018 09/29/2018 P01 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)
RFA-CA-18-008 See Related NCI 12/04/2017 01/28/2018 09/29/2018 U54 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
RFA-CA-18-007 See Related NCI 12/04/2017 01/28/2018 09/29/2018 U01 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)
RFA-CA-18-006 See Related NCI 12/04/2017 01/28/2018 09/29/2018 R01 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)
PAR-18-252 See Related NCI 11/30/2017 05/22/2018 11/23/2018 R01 Image-guided Drug Delivery (R01 Clinical Trial Optional)
PAR-18-251 See Related NCI 11/30/2017 05/14/2018 06/14/2019 R01 Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)
PAR-18-250 See Related NCI 11/30/2017 05/14/2018 06/14/2019 R21 Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional)
PAR-18-248 See Related NCI 11/29/2017 04/09/2018 01/10/2020 UG3/UH3 Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)
PAR-18-247 See Related NCI 11/28/2017 03/12/2018 04/12/2019 R21 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)
PAR-18-246 See Related NCI 11/28/2017 03/12/2018 04/12/2019 R01 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)
PAR-18-024 See Related NCI 11/28/2017 03/12/2018 04/12/2019 R21 Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)
PAR-18-023 See Related NCI 11/28/2017 03/05/2018 01/08/2020 R01 Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)
PAR-18-022 See Related NCI 11/28/2017 03/04/2018 01/08/2020 R21 Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)
PAR-18-021 See Related NCI 11/21/2017 01/28/2018 01/08/2020 R03 NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)
PAR-18-366 See Related NCI 11/20/2017 01/12/2018 01/08/2021 K22 NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)
PAR-18-367 See Related NCI 11/20/2017 01/12/2018 01/08/2021 K22 NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
RFA-CA-18-004 See Related NCI 11/20/2017 01/28/2018 09/29/2018 R21 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
RFA-CA-18-003 See Related NCI 11/20/2017 01/28/2018 09/29/2018 R33 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
RFA-CA-18-002 See Related NCI 11/20/2017 01/28/2018 09/29/2018 R21 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
RFA-CA-18-005 See Related NCI 11/20/2017 01/28/2018 09/29/2018 R33 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
PAR-18-364 See Related NCI 11/17/2017 01/12/2018 01/08/2021 K01 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed)
PAR-18-365 See Related NCI 11/17/2017 01/12/2018 01/08/2021 K01 NCI Mentored Research Scientist Development Award to Promote Diversity (Parent K01 - Clinical Trial Required)
PAR-18-020 See Related NCI 11/17/2017 01/20/2018 03/23/2019 R21 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-18-018 See Related NCI 11/15/2017 01/17/2018 05/08/2019 R21 Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
PA-18-286 See Related NCI 11/13/2017 01/16/2018 01/08/2019 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
PAR-18-019 See Related NCI 11/08/2017 01/17/2018 07/17/2019 R21 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
PAR-18-008 See Related NCI 11/08/2017 01/06/2018 07/06/2019 R01 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
PAR-18-011 See Related NCI 11/06/2017 01/15/2018 02/15/2020 R01 Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)
PAR-18-017 See Related NCI 11/03/2017 01/17/2018 05/08/2019 R21 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PA-18-015 See Related NCI 11/03/2017 01/17/2018 01/08/2020 R21 Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)
PA-18-014 See Related NCI 11/03/2017 01/17/2018 01/08/2020 R21 Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)
PAR-18-007 See Related NCI 11/03/2017 01/06/2018 05/08/2019 R01 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
PA-18-005 See Related NCI 11/03/2017 01/06/2018 01/08/2020 R01 Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)
PA-18-004 See Related NCI 11/03/2017 01/06/2018 01/08/2020 R01 Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)
PA-18-013 See Related NCI 11/02/2017 01/17/2018 01/08/2019 R21 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
PA-18-012 See Related NCI 11/02/2017 01/17/2018 01/08/2019 R21 Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional)
PA-18-003 See Related NCI 11/02/2017 01/06/2018 01/08/2019 R01 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
PA-18-002 See Related NCI 11/02/2017 01/06/2018 01/08/2019 R01 Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)
PAR-18-009 See Related NCI 11/01/2017 01/06/2018 11/06/2019 R01 Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)
PAR-18-337 See Related NCI 10/31/2017 01/12/2018 01/08/2021 K08 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)
PAR-18-336 See Related NCI 10/31/2017 01/12/2018 01/08/2021 K08 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)
PAR-18-290 See Related NCI 10/30/2017 12/26/2017 01/08/2020 P01 National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
PAR-18-317 See Related NCI 10/12/2017 01/14/2018 10/09/2020 UH2/UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
PAR-18-310 See Related NCI 10/12/2017 01/14/2018 10/09/2020 UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed
PAR-18-313 See Related NCI 10/12/2017 12/25/2017 01/08/2021 P50 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
PAR-18-303 See Related NCI 10/03/2017 03/05/2018 01/08/2021 R43/R44 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)
PAR-17-496 See Related NCI 09/29/2017 04/14/2018 05/15/2020 R01 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
PAR-17-464 See Related NCI 09/29/2017 04/14/2018 05/15/2020 R21 Research to Improve Native American Health (R21 Clinical Trial Optional)
PA-17-495 See Related NCI 09/29/2017 01/05/2018 01/08/2021 R01 Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)
PA-17-460 See Related NCI 08/16/2017 01/16/2018 01/08/2021 R01 Biology of Lung, and Head and Neck Preneoplasias (R21 - Clinical Trial Not Allowed)
PA-17-459 See Related NCI 08/15/2017 01/05/2018 01/08/2021 R01 Biology of Lung, and Head and Neck Preneoplasias (R01)
PA-17-449 See Related NCI 08/04/2017 09/16/2017 09/08/2020 R21 The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
PA-17-440 See Related NCI 08/04/2017 09/05/2017 09/08/2020 R01 The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
PAR-17-438 See Related NCI 07/27/2017 09/05/2017 09/08/2020 R01 Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
PA-17-330 See Related NCI 07/21/2017 09/05/2017 09/08/2020 R01 Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
PAR-17-331 See Related NCI 07/20/2017 09/05/2017 09/08/2020 R01 Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
PA-17-298 See Related NCI 06/22/2017 09/05/2017 09/08/2020 R01 Integration of Individual Residential Histories into Cancer Research (R01)
PA-17-295 See Related NCI 06/22/2017 09/16/2017 09/08/2020 R21 Integration of Individual Residential Histories into Cancer Research (R21)
PA-17-289 See Related NCI 05/16/2017 09/05/2017 09/08/2020 R01 Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)
PA-17-288 See Related NCI 05/16/2017 09/16/2017 09/08/2020 R21 Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)
PAR-17-244 See Related NCI 04/04/2017 05/05/2017 05/08/2020 R01 Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
PAR-17-245 See Related NCI 04/03/2017 05/05/2017 05/08/2020 R01 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
PA-17-239 See Related NCI 03/30/2017 05/05/2017 05/08/2020 R01 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
PA-17-243 See Related NCI 03/30/2017 05/16/2017 05/08/2020 R21 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
PAR-17-240 See Related NCI 03/30/2017 10/21/2017 05/22/2020 R01 Innovative Research in Cancer Nanotechnology (IRCN) (R01)
PAR-17-233 See Related NCI 03/29/2017 05/05/2017 05/08/2020 U01 Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)
PAR-17-206 See Related NCI 03/08/2017 05/08/2017 02/08/2019 U01 Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)
PAR-17-207 See Related NCI 03/08/2017 05/08/2017 02/08/2019 U01 Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)
PAR-17-204 See Related NCI 03/07/2017 07/16/2017 01/16/2020 R21 Inter-organelle Communication in Cancer (R21)
PAR-17-203 See Related NCI 03/07/2017 07/16/2017 01/16/2020 R01 Inter-organelle Communication in Cancer (R01)
PAR-17-171 See Related NCI 02/21/2017 05/05/2017 01/08/2019 R01 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)
PAR-17-095 See Related NCI 12/21/2016 12/25/2016 01/08/2020 P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
PAR-17-059 See Related NCI 11/25/2016 12/25/2016 09/08/2019 R25 National Cancer Institute Youth Enjoy Science Research Education Program (R25)
PAR-17-003 See Related NCI 10/04/2016 01/28/2017 10/29/2019 R01 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)
PA-16-425 See Related NCI 09/07/2016 12/07/2016 09/08/2019 R21 "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
PA-16-426 See Related NCI 09/07/2016 12/07/2016 09/08/2019 R01 "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)
PAR-16-349 See Related NCI 06/29/2016 09/14/2016 04/17/2019 UG3/UH3 New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3)
PAR-16-344 See Related NCI 06/24/2016 08/14/2016 03/07/2019 U01 Biological Comparisons in Patient-Derived Models of Cancer (U01)
PAR-16-337 See Related NCI 06/16/2016 09/16/2016 07/17/2019 R03 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)
PAR-16-277 See Related NCI 05/23/2016 09/13/2016 06/14/2019 R21 Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)
PAR-16-276 See Related NCI 05/23/2016 09/13/2016 06/14/2019 R01 Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
PA-16-258 See Related NCI 05/16/2016 09/16/2016 09/08/2019 R21 Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
PAR-16-255 See Related NCI 05/11/2016 01/07/2017 06/15/2019 R21 Cancer-related Behavioral Research through Integrating Existing Data (R21)
PAR-16-256 See Related NCI 05/11/2016 01/07/2017 06/08/2019 R01 Cancer-related Behavioral Research through Integrating Existing Data (R01)
PA-16-251 See Related NCI 05/10/2016 09/05/2016 05/08/2019 R01 Gene Fusions in Pediatric Sarcomas (R01)
PA-16-252 See Related NCI 05/10/2016 09/16/2016 05/08/2019 R21 Gene Fusions in Pediatric Sarcomas (R21)
PAR-16-237 See Related NCI 05/10/2016 05/16/2016 05/08/2019 R03 Dissemination and Implementation Research in Health (R03)
PAR-16-246 See Related NCI 05/09/2016 09/26/2016 06/28/2019 R21 Neural Regulation of Cancer (R21)
PAR-16-245 See Related NCI 05/09/2016 09/26/2016 06/28/2019 R01 Neural Regulation of Cancer (R01)
PAR-16-228 See Related NCI 05/06/2016 09/05/2016 09/08/2019 R01 Metabolic Reprogramming to Improve Immunotherapy (R01)
PAR-16-229 See Related NCI 05/06/2016 09/16/2016 09/08/2019 R21 Metabolic Reprogramming to Improve Immunotherapy (R21)
PAR-16-226 See Related NCI 05/05/2016 09/16/2016 09/08/2019 R21 The Role of Mobile Genetic Elements in Cancer (R21)
PAR-16-227 See Related NCI 05/05/2016 09/05/2016 09/08/2019 R01 The Role of Mobile Genetic Elements in Cancer (R01)
PA-16-175 See Related NCI 04/08/2016 09/16/2016 05/08/2019 R21 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
PA-16-177 See Related NCI 04/08/2016 09/16/2016 07/17/2019 R21 Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)
PAR-16-139 See Related NCI 03/17/2016 04/25/2016 09/25/2018 R25 Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)
PAR-16-138 See Related NCI 03/17/2016 04/25/2016 09/25/2018 R25 Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)
PAR-16-131 See Related NCI 03/11/2016 05/24/2016 11/24/2018 U01 Emerging Questions in Cancer Systems Biology (U01)
PAR-16-089 See Related NCI 01/25/2016 06/11/2016 12/12/2018 U01 Imaging and Biomarkers for Early Cancer Detection (U01)
PAR-16-049 See Related NCI 12/07/2015 02/17/2016 11/18/2018 U01 Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)
PAR-15-333 See Related NCI 08/18/2015 10/20/2015 11/21/2018 U24 Sustained Support for Informatics Resources for Cancer Research and Management (U24)
PAR-15-331 See Related NCI 08/18/2015 10/20/2015 11/21/2018 U24 Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
PAR-15-332 See Related NCI 08/18/2015 10/20/2015 11/21/2018 U01 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
PAR-15-334 See Related NCI 08/18/2015 10/20/2015 11/21/2018 R21 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)
PAR-18-912 See Related NEI 09/07/2018 10/08/2018 11/10/2020 R01 U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
PAR-18-864 See Related NEI 07/19/2018 08/25/2018 09/08/2021 UG1 NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
PAR-18-726 See Related NEI 03/28/2018 05/11/2018 06/12/2020 K12 NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
PAR-18-707 See Related NEI 03/06/2018 03/10/2018 04/10/2020 R24 NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
RFA-EY-18-001 See Related NEI 03/02/2018 04/01/2018 10/30/2020 R21 BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
PA-18-635 See Related NEI 02/06/2018 05/25/2018 05/08/2021 R15 NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional)
PAR-18-523 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
PAR-18-522 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
PAR-18-521 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
PA-18-500 See Related NEI 12/15/2017 01/16/2018 01/08/2021 R21 Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)
PA-18-351 See Related NEI 11/08/2017 01/05/2018 01/08/2021 R01 Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional)
PAR-17-322 See Related NEI 06/23/2017 08/28/2017 09/19/2019 P30 NEI Center Core Grant for Vision Research (P30)
PAR-16-168 See Related NEI 04/06/2016 05/05/2016 05/08/2019 R21 NEI Research Grant for Vision Related Secondary Data Analysis (R21)
PA-16-038 See Related NEI 11/18/2015 01/16/2016 01/08/2019 R34 NEI Clinical Study Planning Grant Program (R34)
RFA-HG-18-006 See Related NHGRI 07/31/2018 09/30/2018 10/21/2020 R35 Genomic Innovator Award (R35 Clinical Trial Optional)
RFA-HG-18-008 See Related NHGRI 07/25/2018 10/08/2018 11/09/2018 U24 Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
PA-18-867 See Related NHGRI 07/23/2018 09/16/2018 07/17/2021 R21 Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
PA-18-868 See Related NHGRI 07/23/2018 09/05/2018 07/06/2021 R01 Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
PAR-18-844 See Related NHGRI 06/28/2018 10/16/2018 09/08/2021 R01 Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
PAR-18-843 See Related NHGRI 06/28/2018 10/16/2018 09/08/2021 R21 Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
PAR-18-777 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R01 Novel Genomic Technology Development (R01 Clinical Trial Not Allowed)
PAR-18-779 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R43/R44 Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed)
PAR-18-778 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R21 Novel Genomic Technology Development (R21 Clinical Trial Not Allowed)
RFA-HG-18-002 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R21 Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
RFA-HG-18-001 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R01 Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
RFA-HG-18-003 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R43/R44 Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
PAR-18-735 See Related NHGRI 04/02/2018 05/21/2018 01/23/2021 R01 Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
PAR-18-736 See Related NHGRI 04/02/2018 05/21/2018 01/23/2021 R21 Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
PAR-17-482 See Related NHGRI 09/13/2017 01/05/2018 01/08/2021 R01 Comparative Genomics Research Program (R01)
PA-17-444 See Related NHGRI 08/01/2017 09/05/2017 09/08/2020 R01 Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
PA-17-445 See Related NHGRI 08/01/2017 09/16/2017 09/08/2020 R03 Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
PA-17-446 See Related NHGRI 08/01/2017 09/16/2017 09/08/2020 R21 Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
PAR-17-273 See Related NHGRI 05/08/2017 06/13/2017 01/26/2020 U24 Genomic Community Resources (U24)
PAR-17-269 See Related NHGRI 05/03/2017 05/17/2017 07/11/2020 X01 Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
PAR-16-436 See Related NHGRI 09/19/2016 04/23/2017 05/21/2019 RM1 Centers of Excellence in Genomic Science (CEGS) (RM1)
PA-16-435 See Related NHGRI 09/19/2016 04/07/2017 05/08/2020 R01 Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
PAR-16-345 See Related NHGRI 06/27/2016 08/25/2016 05/26/2019 R25 Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
PAR-16-275 See Related NHGRI 05/19/2016 09/04/2016 09/08/2019 R01 Serious Adverse Drug Reaction Research (R01)
PAR-16-274 See Related NHGRI 05/19/2016 09/04/2016 09/08/2019 R21 Serious Adverse Drug Reaction Research (R21)
PAR-16-090 See Related NHGRI 01/27/2016 04/25/2016 01/26/2019 R25 Initiative to Maximize Research Education in Genomics: Courses for Skills Development (R25)
RFA-HL-19-006 See Related NHLBI 08/02/2018 09/30/2018 11/01/2018 U24 Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure)
RFA-HL-19-005 See Related NHLBI 08/02/2018 09/30/2018 11/01/2018 UG3/UH3 Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
RFA-HL-18-035 See Related NHLBI 08/01/2018 09/19/2018 10/20/2018 U44 Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed)
RFA-HL-18-033 See Related NHLBI 08/01/2018 09/19/2018 10/20/2018 UT2 Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed)
RFA-HL-18-031 See Related NHLBI 08/01/2018 09/19/2018 10/20/2018 UG3/UH3 Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
RFA-HL-18-030 See Related NHLBI 08/01/2018 09/19/2018 10/20/2018 U01 Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
RFA-HL-19-020 See Related NHLBI 07/27/2018 09/30/2018 11/01/2018 U01 Molecular Atlas of Lung Development Program (LungMAP) Phase 2 Research Centers (U01- Clinical Trial Not Allowed)
RFA-HL-19-021 See Related NHLBI 07/27/2018 09/30/2018 11/01/2018 U01 Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Clinical Trial Not Allowed)
RFA-HL-19-022 See Related NHLBI 07/27/2018 09/30/2018 11/01/2018 U24 Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
RFA-HL-19-025 See Related NHLBI 07/19/2018 09/10/2018 05/07/2021 K01 Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
RFA-HL-19-026 See Related NHLBI 07/19/2018 09/10/2018 05/07/2021 K01 Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
RFA-HL-19-017 See Related NHLBI 05/16/2018 06/27/2018 07/10/2020 R44 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)
RFA-HL-19-018 See Related NHLBI 05/16/2018 06/27/2018 07/10/2020 R44 NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
PA-18-784 See Related NHLBI 05/15/2018 09/05/2018 09/08/2021 R01 The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed)
PAR-18-771 See Related NHLBI 05/09/2018 05/12/2018 01/08/2021 K22 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
PAR-18-772 See Related NHLBI 05/09/2018 05/12/2018 01/08/2021 K22 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
RFA-HL-19-027 See Related NHLBI 05/03/2018 06/19/2018 10/20/2018 U34 Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34 Clinical Trial Not Allowed)
PAR-18-768 See Related NHLBI 05/03/2018 06/19/2018 10/20/2018 X01 Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01 Clinical Trial Not Allowed)
RFA-HL-19-024 See Related NHLBI 05/01/2018 08/10/2018 05/07/2021 R25 Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
RFA-HL-19-023 See Related NHLBI 04/27/2018 08/04/2018 05/07/2021 T32 T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
RFA-HL-19-015 See Related NHLBI 03/30/2018 05/04/2018 09/11/2020 R01 Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)
RFA-HL-19-016 See Related NHLBI 03/15/2018 05/11/2018 09/11/2020 R43 Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed)
RFA-HL-19-014 See Related NHLBI 03/05/2018 05/14/2018 06/16/2020 R01 Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)
PAR-18-683 See Related NHLBI 02/27/2018 05/04/2018 01/08/2021 R61/R33 NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
PAR-18-684 See Related NHLBI 02/27/2018 05/04/2018 01/08/2021 R33 NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
PAR-18-643 See Related NHLBI 02/08/2018 03/30/2018 12/19/2020 R01 NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
PAR-18-577 See Related NHLBI 01/12/2018 05/05/2018 06/06/2020 U01 New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed)
PAR-18-463 See Related NHLBI 12/01/2017 01/16/2018 01/08/2021 R34 NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional)
PAR-18-132 See Related NHLBI 11/08/2017 01/17/2018 01/08/2020 R21 Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional)
PAR-18-126 See Related NHLBI 11/08/2017 01/06/2018 01/08/2020 R01 Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional)
PAR-18-406 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 R61/R33 Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
PAR-18-407 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 UG3/UH3 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required
PAR-18-410 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 U24 Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
PAR-18-405 See Related NHLBI 10/20/2017 12/25/2017 01/08/2021 P01 NHLBI Program Project Applications (P01 - Clinical Trials Optional)
RFA-HL-18-025 See Related NHLBI 10/06/2017 01/15/2018 01/08/2019 R03 Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) - (Clinical Trial Optional)
RFA-HL-18-023 See Related NHLBI 08/23/2017 09/24/2017 05/13/2020 R38 Stimulating Access to Research in Residency (StARR) (R38)
PAR-17-338 See Related NHLBI 08/21/2017 01/22/2018 02/21/2020 U01 Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
PAR-17-004 See Related NHLBI 10/06/2016 01/24/2017 10/31/2019 R21 Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
RFA-HL-17-022 See Related NHLBI 08/29/2016 01/16/2017 01/08/2020 R21 Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
PAR-16-021 See Related NHLBI 10/30/2015 12/19/2015 01/19/2019 X01 NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)
RFA-AG-19-024 See Related NIA 09/11/2018 01/04/2019 02/05/2019 U24 Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)
RFA-AG-19-022 See Related NIA 08/15/2018 11/03/2018 12/04/2018 U24 Research Network on Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility (U24 Clinical Trial Not Allowed)
RFA-AG-19-023 See Related NIA 08/15/2018 11/03/2018 12/04/2018 U01 Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility: A Methods Comparison Study (U01 Clinical Trial Optional)
RFA-AG-19-020 See Related NIA 08/08/2018 11/17/2018 12/18/2018 U19 Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)
PAR-18-890 See Related NIA 08/03/2018 09/05/2018 09/08/2021 U01 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)
PAR-18-889 See Related NIA 08/03/2018 09/05/2018 09/08/2021 U01 Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)
RFA-AG-19-010 See Related NIA 08/02/2018 01/01/2019 02/02/2019 U54 Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)
PAR-18-878 See Related NIA 07/26/2018 09/05/2018 09/08/2021 R01 Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
PAR-18-877 See Related NIA 07/26/2018 09/05/2018 09/08/2021 R01 Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)
RFA-AG-19-021 See Related NIA 07/25/2018 09/23/2018 10/24/2018 R03 Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
RFA-AG-19-019 See Related NIA 07/03/2018 09/01/2018 10/02/2018 U01 The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed)
RFA-AG-19-011 See Related NIA 06/27/2018 10/14/2018 11/15/2018 UH2/UH3 Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed)
RFA-AG-19-015 See Related NIA 06/21/2018 01/01/2019 02/02/2019 R24 High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
RFA-AG-19-016 See Related NIA 06/21/2018 01/01/2019 02/02/2019 R24 High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed)
RFA-AG-19-017 See Related NIA 06/08/2018 09/24/2018 10/25/2018 K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
RFA-AG-19-018 See Related NIA 06/08/2018 09/24/2018 10/25/2018 K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required)
PA-18-825 See Related NIA 06/08/2018 09/05/2018 09/08/2021 R01 Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed)
PA-18-826 See Related NIA 06/08/2018 09/16/2018 09/08/2021 R21 Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 - Clinical Trial Not Allowed)
PA-18-824 See Related NIA 06/08/2018 09/16/2018 09/08/2021 R21 Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 - Clinical Trial Not Allowed)
PA-18-823 See Related NIA 06/08/2018 09/05/2018 09/08/2021 R01 Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed)
RFA-AG-19-008 See Related NIA 06/07/2018 09/18/2018 10/19/2018 R24 Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
RFA-AG-19-007 See Related NIA 06/07/2018 09/18/2018 10/19/2018 P30 Roybal Centers for Translational Research on Dementia Care Provider Support (P30 - Clinical Trial Required)
RFA-AG-19-006 See Related NIA 06/07/2018 09/18/2018 10/19/2018 P30 Roybal Centers for Translational Research on Aging (P30 - Clinical Trial Required)
PAR-18-820 See Related NIA 06/07/2018 09/05/2018 09/08/2021 U01 Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
RFA-AG-19-005 See Related NIA 05/14/2018 09/18/2018 10/19/2018 R24 Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional)
PAR-18-760 See Related NIA 04/18/2018 05/16/2018 01/08/2021 R21 In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
PAR-18-749 See Related NIA 04/10/2018 08/25/2018 01/26/2021 R24 Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)
PAR-18-715 See Related NIA 03/21/2018 05/05/2018 05/08/2021 U01 NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed)
PAR-18-706 See Related NIA 03/06/2018 05/05/2018 11/06/2019 R01 Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
PAR-18-644 See Related NIA 02/08/2018 02/16/2018 09/08/2019 R33 Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)
PAR-18-645 See Related NIA 02/08/2018 02/16/2018 09/08/2019 R21/R33 Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
PAR-18-587 See Related NIA 01/26/2018 03/10/2018 01/09/2020 R41/R42 Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional)
PAR-18-588 See Related NIA 01/26/2018 03/10/2018 01/09/2020 R43/R44 Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional)
PAR-18-585 See Related NIA 01/24/2018 02/23/2018 02/21/2020 R61/R33 Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)
PAR-18-582 See Related NIA 01/12/2018 02/27/2018 06/23/2020 R21 Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed)
PAR-18-581 See Related NIA 01/12/2018 02/27/2018 06/09/2020 R01 Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional)
PA-18-571 See Related NIA 01/11/2018 05/16/2018 05/08/2021 R03 Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional)
PA-18-570 See Related NIA 01/11/2018 05/05/2018 05/08/2021 R01 Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional)
PA-18-572 See Related NIA 01/11/2018 05/16/2018 05/08/2021 R21 Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional)
PAR-18-538 See Related NIA 12/21/2017 02/27/2018 06/23/2020 R21 Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
PAR-18-544 See Related NIA 12/21/2017 02/27/2018 06/09/2020 R01 Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
PAR-18-524 See Related NIA 12/21/2017 02/27/2018 01/08/2021 T32 Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)
PA-18-545 See Related NIA 12/21/2017 01/05/2018 01/08/2019 R01 Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)
PAR-18-514 See Related NIA 12/20/2017 03/05/2018 01/06/2021 R41/R42 Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
PAR-18-512 See Related NIA 12/20/2017 03/05/2018 01/06/2021 R43/R44 Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
PAR-18-519 See Related NIA 12/20/2017 02/23/2018 11/07/2020 R01 Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)
PAR-18-516 See Related NIA 12/19/2017 02/27/2018 11/08/2020 R01 Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
PAR-18-513 See Related NIA 12/18/2017 02/27/2018 01/08/2021 R01 Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
PA-18-503 See Related NIA 12/15/2017 01/16/2018 05/08/2020 R21 Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)
PA-18-502 See Related NIA 12/15/2017 01/05/2018 05/08/2020 R01 Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)
PAR-18-497 See Related NIA 12/15/2017 02/23/2018 11/07/2020 R01 Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed)
PAR-18-190 See Related NIA 11/29/2017 04/07/2018 09/08/2020 R21 Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
PAR-18-189 See Related NIA 11/29/2017 04/07/2018 09/08/2020 R01 Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAS-18-188 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R41/R42 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
PAS-18-187 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
PAR-18-186 See Related NIA 11/28/2017 03/06/2018 04/06/2020 R43/R44 Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)
PAR-18-185 See Related NIA 11/28/2017 03/06/2018 04/06/2020 R41/R42 Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)
PAR-18-184 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
PAR-18-183 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
PAR-18-179 See Related NIA 11/06/2017 01/17/2018 01/08/2019 R21 Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)
PAR-18-027 See Related NIA 11/06/2017 01/06/2018 01/08/2019 R01 Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)
PAR-18-297 See Related NIA 11/01/2017 12/26/2017 09/10/2019 P01 NIA Program Project Applications (P01 Clinical Trial Optional)
PAR-18-296 See Related NIA 11/01/2017 12/26/2017 09/08/2019 U19 Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
PAR-18-181 See Related NIA 11/01/2017 01/17/2018 01/08/2020 R21/R33 Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)
PAS-18-030 See Related NIA 11/01/2017 01/06/2018 01/08/2020 R01 Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
PA-18-025 See Related NIA 11/01/2017 01/06/2018 05/08/2020 R01 Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)
PAR-18-030 See Related NIA 10/30/2017 12/26/2017 09/08/2019 P01 NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)
PAR-18-029 See Related NIA 10/30/2017 01/06/2018 01/08/2020 R01 Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)
PAR-18-329 See Related NIA 10/25/2017 12/05/2017 01/06/2020 R43/R44 Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
PAR-18-326 See Related NIA 10/25/2017 12/05/2017 01/06/2020 R41/R42 Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
PAR-17-290 See Related NIA 05/16/2017 08/25/2017 09/08/2020 R25 NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25)
PAR-17-287 See Related NIA 05/15/2017 09/12/2017 09/08/2020 K07 NIA Academic Leadership Career Award (K07)
PAR-17-214 See Related NIA 03/10/2017 05/05/2017 05/08/2020 U01 Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)
PAR-17-127 See Related NIA 01/18/2017 05/16/2017 03/17/2020 R03 Juvenile Protective Factors and Their Effects on Aging (R03)
PAR-17-126 See Related NIA 01/18/2017 05/05/2017 03/06/2020 R01 Juvenile Protective Factors and Their Effects on Aging (R01)
PA-17-089 See Related NIA 12/16/2016 05/16/2017 05/08/2020 R21 Exploratory Analyses of Existing Cohorts, Data Sets, and Stored Biospecimens to Address Clinical Aging Research Questions (R21)
PA-17-088 See Related NIA 12/16/2016 05/05/2017 05/08/2020 R01 Secondary Analyses of Existing Cohorts, Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01)
PAR-17-072 See Related NIA 12/09/2016 02/02/2017 01/26/2019 T32 Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32)
PAR-17-066 See Related NIA 12/02/2016 03/05/2017 09/06/2019 R41/R42 Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42)
PAR-17-067 See Related NIA 12/02/2016 03/05/2017 09/06/2019 R43/R44 Tools for Clinical Care and Management of Alzheimers Disease (AD) and its Comorbidities (R43/R44)
PAR-17-054 See Related NIA 11/16/2016 01/05/2017 11/06/2019 R01 Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01)
PAR-17-052 See Related NIA 11/07/2016 01/12/2017 01/08/2020 K18 Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)
PAR-17-039 See Related NIA 10/27/2016 01/16/2017 01/08/2020 R21 Comparative Biology of Neurodegeneration (R21)
PAR-17-033 See Related NIA 10/25/2016 01/05/2017 01/08/2020 R01 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
PAR-17-032 See Related NIA 10/25/2016 01/05/2017 01/08/2020 R01 Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)
PAR-17-031 See Related NIA 10/25/2016 01/05/2017 10/06/2019 R01 Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)
PAR-17-029 See Related NIA 10/21/2016 01/05/2017 11/06/2019 R01 Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01)
PAS-17-026 See Related NIA 10/21/2016 01/16/2017 01/08/2020 R03 Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)
PAR-17-025 See Related NIA 10/20/2016 01/16/2017 01/08/2020 R36 Aging Research Dissertation Awards to Increase Diversity (R36)
PAR-17-024 See Related NIA 10/20/2016 12/25/2016 01/26/2020 U19 Limited Competition: Renewal of the Longevity Consortium (U19)
PAR-17-020 See Related NIA 10/19/2016 12/25/2016 01/08/2020 P50 Revision Requests for Active Alzheimer's Disease Research Centers (P50)
PAR-17-019 See Related NIA 10/19/2016 12/25/2016 01/08/2020 P30 Revision Requests for Active Alzheimer's Disease Core Centers (P30)
PA-16-442 See Related NIA 09/22/2016 01/05/2017 01/08/2020 R01 Changes in Cellular Architecture During Aging (R01)
PAR-16-406 See Related NIA 08/15/2016 09/05/2016 09/08/2019 U01 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01)
PAR-16-371 See Related NIA 07/15/2016 09/16/2016 09/08/2019 R21 Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R21)
PAR-16-370 See Related NIA 07/15/2016 09/05/2016 09/08/2019 R01 Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R01)
PA-16-240 See Related NIA 05/09/2016 09/16/2016 09/08/2019 R21 Mechanisms Mediating Osteoarthritis in Aging (R21)
PA-16-239 See Related NIA 05/09/2016 09/05/2016 09/08/2019 R01 Mechanisms Mediating Osteoarthritis in Aging (R01)
PA-16-231 See Related NIA 05/06/2016 09/16/2016 09/08/2019 R21 Non-healing Ulcerative Wounds in Aging (R21)
PA-16-230 See Related NIA 05/06/2016 09/05/2016 09/08/2019 R01 Non-healing Ulcerative Wounds in Aging (R01)
PAR-16-205 See Related NIA 04/19/2016 08/25/2016 09/08/2019 U24 The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS) (U24)
PAR-16-085 See Related NIA 01/15/2016 05/16/2016 03/17/2019 R34 NIA Clinical Research Project Planning Grant Program (R34)
PAR-16-047 See Related NIA 12/04/2015 04/25/2016 09/26/2018 U24 National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24)
PAR-15-359 See Related NIA 09/25/2015 11/11/2015 01/08/2019 R01 Novel Approaches to Diagnosing Alzheimer's Disease & Predicting Progression (R01)
PAR-15-358 See Related NIA 09/25/2015 11/10/2015 01/08/2019 R01 Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (R01)
PAR-15-357 See Related NIA 09/24/2015 11/16/2015 01/08/2019 R01 Understanding Alzheimer's Disease in the Context of the Aging Brain (R01)
PAR-15-356 See Related NIA 09/24/2015 11/11/2015 01/08/2019 R01 Major Opportunities for Research in Epidemiology of Alzheimer's Disease and Cognitive Resilience (R01)
PAR-15-350 See Related NIA 09/17/2015 11/17/2015 01/08/2019 R03 Emerging Directions for Addressing Health Disparities in Alzheimer's Disease (R03)
PAR-15-349 See Related NIA 09/17/2015 11/11/2015 01/08/2019 R01 Health Disparities and Alzheimer's Disease (R01)
PA-18-863 See Related NIAAA 07/19/2018 09/05/2018 09/08/2021 R01 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional)
PA-18-861 See Related NIAAA 07/19/2018 09/05/2018 01/08/2022 R03 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional)
PA-18-862 See Related NIAAA 07/19/2018 09/16/2018 09/08/2021 R21 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional)
PA-18-785 See Related NIAAA 05/15/2018 08/05/2018 04/06/2021 R41/R42 Wearable Alcohol Biosensors (STTR) (R41/R42- Clinical Trial Optional)
PA-18-786 See Related NIAAA 05/15/2018 08/05/2018 04/06/2021 R43/R44 Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)
PA-18-660 See Related NIAAA 02/14/2018 05/05/2018 05/08/2021 R01 Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)
PAR-18-659 See Related NIAAA 02/14/2018 05/16/2018 05/08/2021 R21/R33 Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed)
PA-18-647 See Related NIAAA 02/08/2018 06/01/2018 03/02/2021 Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional)
PA-18-619 See Related NIAAA 02/02/2018 05/05/2018 05/08/2021 R01 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional)
PA-18-620 See Related NIAAA 02/02/2018 05/16/2018 05/08/2021 R21 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional)
PAR-18-580 See Related NIAAA 01/12/2018 02/27/2018 12/05/2020 UT2 Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional)
PAR-18-578 See Related NIAAA 01/12/2018 02/27/2018 12/05/2020 U44 Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)
PAS-18-557 See Related NIAAA 01/02/2018 01/05/2018 05/08/2020 R01 Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
PA-18-508 See Related NIAAA 12/19/2017 05/16/2018 01/08/2021 R21 Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional)
PA-18-507 See Related NIAAA 12/19/2017 05/05/2018 01/08/2021 R01 Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)
PA-18-413 See Related NIAAA 11/27/2017 01/16/2018 05/08/2020 R03 Epidemiology and Prevention in Alcohol Research (R03 - Clinical Trial - Optional)
PA-18-391 See Related NIAAA 11/27/2017 01/16/2018 05/08/2020 R21 Epidemiology and Prevention in Alcohol Research (R21 - Clinical Trial Optional)
PA-18-390 See Related NIAAA 11/27/2017 01/05/2018 05/08/2020 R01 Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional)
PAR-18-203 See Related NIAAA 11/17/2017 01/17/2018 05/08/2020 R21/R33 Leveraging Electronic Health Records for Alcohol Services Research (R21/R33 Clinical Trial Optional)
PAR-18-196 See Related NIAAA 11/01/2017 01/06/2018 05/08/2020 R01 Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional)
PAR-18-195 See Related NIAAA 11/01/2017 01/06/2018 05/08/2019 U01 Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional)
PA-17-467 See Related NIAAA 08/23/2017 09/05/2017 09/08/2020 R01 Secondary Analyses of Existing Alcohol Research Data (R01)
PA-17-468 See Related NIAAA 08/23/2017 09/16/2017 09/08/2020 R03 Secondary Analyses of Existing Alcohol Research Data (R03)
PA-17-297 See Related NIAAA 05/25/2017 09/05/2017 09/08/2020 R01 Alcohol-Induced Effects on Tissue Injury and Repair (R01)
PA-17-296 See Related NIAAA 05/25/2017 09/16/2017 09/08/2020 R21 Alcohol-Induced Effects on Tissue Injury and Repair (R21)
PA-17-219 See Related NIAAA 03/13/2017 05/16/2017 09/08/2020 R21 Mechanisms of Alcohol-associated Cancers (R21)
PA-17-220 See Related NIAAA 03/13/2017 05/05/2017 09/08/2020 R01 Mechanisms of Alcohol-associated Cancers (R01)
PA-17-211 See Related NIAAA 03/09/2017 05/08/2017 05/08/2020 R01 Nutrition and Alcohol-Related Health Outcomes (R01)
PA-17-212 See Related NIAAA 03/09/2017 05/16/2017 05/08/2020 R03 Nutrition and Alcohol-Related Health Outcomes (R03)
PA-17-213 See Related NIAAA 03/09/2017 05/16/2017 05/08/2020 R21 Nutrition and Alcohol-Related Health Outcomes (R21)
PAR-17-170 See Related NIAAA 02/21/2017 04/25/2017 05/08/2020 R24 Alcohol Research Resource Awards (R24)
PA-17-134 See Related NIAAA 01/25/2017 05/16/2017 05/08/2020 R03 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
PA-17-132 See Related NIAAA 01/25/2017 05/16/2017 05/08/2020 R21 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)
PA-17-135 See Related NIAAA 01/25/2017 05/05/2017 05/08/2020 R01 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)
PA-16-395 See Related NIAAA 08/10/2016 09/05/2016 09/08/2019 R01 Secondary Analyses of Alcohol and Chronic Disease (R01)
PA-16-394 See Related NIAAA 08/10/2016 09/16/2016 09/08/2019 R03 Secondary Analyses of Alcohol and Chronic Disease (R03)
PAR-18-923 See Related NIAID 09/17/2018 12/14/2018 01/15/2021 R21 Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
PAR-18-895 See Related NIAID 08/08/2018 12/07/2018 01/08/2021 R01 CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
PAR-18-879 See Related NIAID 07/26/2018 11/02/2018 12/04/2020 U01 Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
PA-18-873 See Related NIAID 07/24/2018 09/05/2018 09/08/2021 R01 Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
PA-18-872 See Related NIAID 07/24/2018 09/16/2018 09/08/2021 R21 Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
RFA-AI-18-029 See Related NIAID 07/24/2018 11/05/2018 12/06/2018 R01 HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)
PAR-18-860 See Related NIAID 07/19/2018 09/14/2018 10/16/2020 R21 Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
PA-18-859 See Related NIAID 07/18/2018 09/05/2018 09/08/2021 R01 Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
PA-18-858 See Related NIAID 07/18/2018 09/16/2018 09/08/2021 R21 Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
RFA-AI-18-036 See Related NIAID 07/09/2018 12/03/2018 01/04/2019 UM1 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
RFA-AI-18-037 See Related NIAID 07/03/2018 11/05/2018 12/06/2018 R01 Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)
RFA-AI-18-025 See Related NIAID 06/28/2018 10/15/2018 11/16/2018 R21 Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed)
RFA-AI-18-022 See Related NIAID 06/28/2018 09/10/2018 10/10/2019 U01 Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)
RFA-AI-18-026 See Related NIAID 06/19/2018 11/13/2018 12/14/2018 R01 Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)
RFA-AI-18-023 See Related NIAID 06/14/2018 09/04/2018 10/05/2018 R01 Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
RFA-AI-18-006 See Related NIAID 06/11/2018 10/30/2018 12/01/2018 R61/R33 Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)
PAR-18-822 See Related NIAID 06/07/2018 08/04/2018 09/05/2020 R01 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
PAR-18-781 See Related NIAID 05/11/2018 08/04/2018 09/10/2020 R21 Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)
RFA-AI-18-015 See Related NIAID 04/25/2018 08/27/2018 09/28/2018 U01 Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)
PAR-18-764 See Related NIAID 04/20/2018 08/07/2018 05/08/2021 R01 Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
PA-18-753 See Related NIAID 04/11/2018 08/07/2018 05/08/2021 R01 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)
PA-18-754 See Related NIAID 04/11/2018 08/07/2018 05/08/2021 R21 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed)
PA-18-724 See Related NIAID 03/28/2018 05/16/2018 05/08/2021 R21 Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed)
PA-18-725 See Related NIAID 03/28/2018 05/05/2018 05/08/2021 R01 Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)
PAR-18-712 See Related NIAID 03/15/2018 05/05/2018 05/08/2021 R01 Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
PAR-18-679 See Related NIAID 02/23/2018 05/12/2018 05/08/2020 K99/R00 NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
PAR-18-633 See Related NIAID 02/06/2018 04/14/2018 01/14/2021 U01 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-632 See Related NIAID 02/06/2018 04/14/2018 01/14/2021 U44 NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
PAR-18-630 See Related NIAID 02/05/2018 03/10/2018 12/07/2019 R01 Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
PA-18-525 See Related NIAID 12/19/2017 03/05/2018 01/06/2021 R43/R44 Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
PAR-18-411 See Related NIAID 11/16/2017 02/14/2018 03/14/2020 R01 Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
PAR-18-335 See Related NIAID 10/31/2017 06/30/2018 08/01/2020 G11 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed)
PAR-18-319 See Related NIAID 10/13/2017 02/13/2018 03/14/2020 P01 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
PAR-17-471 See Related NIAID 08/25/2017 11/06/2017 12/07/2019 R61/R33 Detection of HIV for Self-Testing (R61/R33)
PAR-17-455 See Related NIAID 08/11/2017 11/06/2017 12/06/2019 R25 NIAID Research Education Program (R25)
PAR-17-439 See Related NIAID 07/28/2017 09/16/2017 09/08/2020 R03 Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03)
PAR-17-332 See Related NIAID 07/21/2017 09/16/2017 07/17/2019 R03 Small Grants on Primary Immunodeficiency Diseases (R03)
PAR-17-333 See Related NIAID 07/21/2017 09/16/2017 07/17/2019 R21 Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
PAR-17-329 See Related NIAID 07/20/2017 08/07/2017 05/08/2020 K99/R00 NIAID Physician-Scientist Pathway to Independence Award (K99/R00)
PA-17-306 See Related NIAID 06/07/2017 08/07/2017 05/08/2020 R21 Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)
PA-17-305 See Related NIAID 06/06/2017 08/07/2017 05/08/2020 R01 Imaging the Persistent HIV Reservoir (R01)
PA-17-282 See Related NIAID 05/12/2017 08/07/2017 09/08/2020 R21 Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
PA-17-283 See Related NIAID 05/12/2017 08/07/2017 09/08/2020 R01 Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
PA-17-279 See Related NIAID 05/12/2017 08/07/2017 05/08/2020 R01 HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)
PA-17-278 See Related NIAID 05/12/2017 08/07/2017 05/08/2020 R21 HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
PA-17-280 See Related NIAID 05/12/2017 08/07/2017 05/08/2020 R01 In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
PA-17-281 See Related NIAID 05/12/2017 08/07/2017 05/08/2020 R21 In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
PAR-17-263 See Related NIAID 04/25/2017 07/01/2017 08/02/2019 R01 Innovation for HIV Vaccine Discovery (R01)
PAR-17-237 See Related NIAID 03/30/2017 07/01/2017 08/18/2019 P30 Centers for AIDS Research (P30)
PAR-17-238 See Related NIAID 03/30/2017 07/01/2017 08/18/2019 P30 Developmental Centers for AIDS Research (P30)
PAR-17-142 See Related NIAID 01/30/2017 04/22/2017 08/23/2019 R01 International Research in Infectious Diseases, including AIDS (R01)
PA-17-114 See Related NIAID 01/09/2017 04/07/2017 01/08/2020 R01 NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
PA-17-113 See Related NIAID 01/09/2017 04/07/2017 01/08/2020 R01 Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
PAR-16-434 See Related NIAID 09/16/2016 09/24/2016 09/08/2019 K22 NIAID Career Transition Award (K22)
PAR-16-413 See Related NIAID 08/18/2016 08/25/2016 09/08/2019 P01 NIAID Investigator Initiated Program Project Applications (P01)
PAR-16-412 See Related NIAID 08/18/2016 08/25/2016 09/08/2019 R24 NIAID Resource-Related Research Projects (R24)
PAR-16-272 See Related NIAID 05/18/2016 08/13/2016 05/14/2019 R34 NIAID Clinical Trial Planning Grant (R34)
PAR-16-262 See Related NIAID 05/17/2016 12/04/2016 01/05/2019 R01 Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01)
PAR-16-254 See Related NIAID 05/11/2016 12/11/2016 01/12/2019 R01 Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01)
PAR-16-253 See Related NIAID 05/10/2016 09/04/2016 10/05/2018 UH2 Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2)
PA-16-244 See Related NIAID 05/09/2016 09/16/2016 09/08/2019 R21 Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21)
PA-16-243 See Related NIAID 05/09/2016 09/05/2016 09/08/2019 R01 Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01)
PA-16-207 See Related NIAID 04/19/2016 08/05/2016 04/06/2019 R43/R44 The Use of mRNA for an HIV Envelope Vaccine (R43/R44)
PA-16-208 See Related NIAID 04/19/2016 08/05/2016 04/06/2019 R41/R42 The Use of mRNA for an HIV Envelope Vaccine (R41/R42)
PA-16-182 See Related NIAID 04/12/2016 08/05/2016 04/06/2019 R41/R42 Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)
PA-16-184 See Related NIAID 04/12/2016 08/05/2016 04/06/2019 R43/R44 Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)
PA-16-163 See Related NIAID 04/04/2016 05/16/2016 05/08/2019 R03 Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
PAR-16-115 See Related NIAID 02/25/2016 04/16/2016 01/10/2019 R01 Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01)
PA-18-914 See Related NIAMS 09/07/2018 10/05/2018 04/06/2021 Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed
PAR-18-900 See Related NIAMS 08/10/2018 09/04/2018 07/04/2019 X02 Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
PAR-18-899 See Related NIAMS 08/10/2018 09/04/2018 07/04/2019 X02 Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
RFA-AR-19-012 See Related NIAMS 07/23/2018 03/09/2019 01/10/2020 R61/R33 Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
RFA-AR-19-013 See Related NIAMS 07/20/2018 03/09/2019 01/10/2020 R61/R33 Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
RFA-AR-19-006 See Related NIAMS 04/04/2018 07/07/2018 04/03/2019 R01 Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
RFA-AR-19-007 See Related NIAMS 04/04/2018 07/07/2018 04/03/2019 R21 Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
PA-18-718 See Related NIAMS 03/28/2018 09/16/2018 09/08/2021 R21 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed)
PA-18-719 See Related NIAMS 03/28/2018 09/05/2018 09/08/2021 R01 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed)
PAR-18-597 See Related NIAMS 01/29/2018 06/02/2018 11/04/2020 R01 Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
PAR-18-595 See Related NIAMS 01/26/2018 02/27/2018 11/04/2020 R21 Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
PAR-18-594 See Related NIAMS 01/26/2018 02/27/2018 11/04/2020 U01 NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
PA-18-408 See Related NIAMS 10/26/2017 01/16/2018 05/08/2021 R21 Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed
PA-18-409 See Related NIAMS 10/26/2017 01/05/2018 05/08/2021 R01 Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed
PAR-16-446 See Related NIAMS 09/23/2016 02/01/2017 11/02/2019 R34 NIAMS Clinical Trial Planning Grant (R34)
RFA-AR-17-002 See Related NIAMS 09/16/2016 12/17/2016 01/18/2019 P30 Core Centers for Clinical Research (CCCR) (P30)
PAR-16-268 See Related NIAMS 05/18/2016 09/19/2016 02/20/2019 R03 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
PA-16-097 See Related NIAMS 02/11/2016 05/05/2016 03/06/2019 R01 Accelerating Research on Intervertebral Disc (ARID) (R01)
PA-16-096 See Related NIAMS 02/11/2016 05/16/2016 03/17/2019 R21 Accelerating Research on Intervertebral Disc (ARID) (R21)
PA-18-851 See Related NIBIB 07/05/2018 08/07/2018 12/12/2018 NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
PA-18-680 See Related NIBIB 02/23/2018 02/23/2018 03/18/2020 Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp Clilnical Trial Not Allowed)
PA-18-631 See Related NIBIB 02/05/2018 03/05/2018 01/06/2021 R44 NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
PAR-18-433 See Related NIBIB 12/15/2017 01/25/2018 01/08/2021 R21 NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)
PAR-18-434 See Related NIBIB 12/15/2017 01/05/2018 09/08/2020 R01 Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)
PA-18-418 See Related NIBIB 11/30/2017 01/05/2018 01/08/2021 R01 NIBIB Research Project Grant (R01 Clinical Trial Required)
PAR-18-207 See Related NIBIB 11/17/2017 01/17/2018 09/08/2019 R21 NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
PAR-18-208 See Related NIBIB 11/07/2017 04/08/2018 01/08/2019 U01 Bioengineering Research Partnerships (U01 Clinical Trial Optional)
PAR-18-206 See Related NIBIB 11/07/2017 01/06/2018 05/08/2019 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
PAR-18-205 See Related NIBIB 10/30/2017 12/26/2017 01/08/2020 P41 NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)
RFA-EB-17-005 See Related NIBIB 10/12/2017 11/15/2017 09/04/2019 R01 BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
RFA-EB-17-003 See Related NIBIB 10/04/2017 11/20/2017 12/12/2018 R01 BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed)
RFA-EB-17-004 See Related NIBIB 10/04/2017 11/20/2017 12/12/2018 U01 BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)
PAR-17-221 See Related NIBIB 03/14/2017 04/24/2017 05/25/2019 R25 Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)
PAR-18-885 See Related NICHD 08/01/2018 11/04/2018 12/05/2020 R21 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
PAR-18-884 See Related NICHD 08/01/2018 11/04/2018 12/05/2020 R01 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
RFA-HD-19-008 See Related NICHD 07/27/2018 09/01/2018 10/02/2018 K12 Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional)
PAR-18-853 See Related NICHD 07/10/2018 10/27/2018 11/28/2020 R61/R33 Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
PA-18-838 See Related NICHD 06/26/2018 09/05/2018 09/08/2021 R01 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
PA-18-839 See Related NICHD 06/26/2018 09/16/2018 09/08/2021 R21 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
PAR-18-834 See Related NICHD 06/18/2018 08/18/2018 09/19/2020 R15 Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed)
RFA-HD-19-015 See Related NICHD 06/15/2018 10/06/2018 11/07/2018 R61/R33 Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
PAR-18-831 See Related NICHD 06/14/2018 10/07/2018 06/04/2021 R21 The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
PAR-18-830 See Related NICHD 06/14/2018 10/07/2018 06/04/2021 R01 The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
PA-18-791 See Related NICHD 05/21/2018 09/16/2018 09/08/2021 R03 Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical Trial Optional)
PA-18-790 See Related NICHD 05/21/2018 09/05/2018 09/08/2021 R01 Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical Trial Optional)
PAR-18-766 See Related NICHD 04/27/2018 09/05/2018 09/08/2021 R01 Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional)
PAR-18-734 See Related NICHD 03/30/2018 05/16/2018 09/08/2019 R03 Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 - Clinical Trial Not Allowed)
PAR-18-733 See Related NICHD 03/30/2018 05/16/2018 09/08/2019 R03 Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
PA-18-729 See Related NICHD 03/28/2018 05/05/2018 01/08/2021 R01 Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
PA-18-728 See Related NICHD 03/28/2018 05/16/2018 01/08/2021 R21 Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
PA-18-687 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R03 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)
PA-18-688 See Related NICHD 03/01/2018 05/05/2018 05/08/2021 R01 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)
PAR-18-689 See Related NICHD 03/01/2018 05/05/2018 05/08/2021 R01 Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional)
PAR-18-690 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R03 Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional)
PAR-18-691 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R21 Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional)
PAR-18-649 See Related NICHD 02/09/2018 02/28/2018 03/31/2019 R03 Human-Animal Interaction (HAI) Research (R03 - Clinical Trial Optional)
PAR-18-650 See Related NICHD 02/09/2018 02/28/2018 03/31/2019 R21 Human-Animal Interaction (HAI) Research (R21 - Clinical Trial Optional)
PAR-18-511 See Related NICHD 12/19/2017 01/05/2018 01/08/2021 R01 Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
PAR-18-506 See Related NICHD 12/18/2017 05/05/2018 05/08/2021 R01 Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
PA-18-485 See Related NICHD 12/11/2017 01/05/2018 01/08/2021 R01 Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)
PA-18-491 See Related NICHD 12/11/2017 01/16/2018 01/08/2021 R03 Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)
PA-18-482 See Related NICHD 12/06/2017 01/16/2018 01/08/2021 R21 NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional)
PA-18-480 See Related NICHD 12/06/2017 01/05/2018 01/08/2021 R01 NICHD Research Project Grant (R01 - Clinical Trial Required)
PA-18-481 See Related NICHD 12/05/2017 01/16/2018 01/08/2021 R03 NICHD Small Grant Program (R03 - Clinical Trial Optional)
PAR-18-217 See Related NICHD 11/29/2017 04/25/2018 05/26/2019 R25 NICHD Research Education Programs (R25 Clinical Trial Optional)
PAR-18-215 See Related NICHD 11/28/2017 03/05/2018 04/04/2020 R01 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
PAR-18-214 See Related NICHD 11/28/2017 03/05/2018 04/04/2020 R21 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
PAR-18-213 See Related NICHD 11/21/2017 02/28/2018 03/31/2019 R01 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
PAR-18-212 See Related NICHD 11/21/2017 02/28/2018 03/30/2019 R01 Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional)
PAR-18-211 See Related NICHD 11/21/2017 02/28/2018 03/30/2019 R03 NCMRR Early Career Research Award (R03 Clinical Trial Optional)
PA-18-093 See Related NICHD 11/15/2017 01/17/2018 05/08/2019 R21 Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21 Clinical Trial Optional)
PA-18-049 See Related NICHD 11/15/2017 01/17/2018 05/08/2020 R21 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
PA-18-048 See Related NICHD 11/15/2017 01/17/2018 01/08/2020 R21 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
PA-18-047 See Related NICHD 11/15/2017 01/17/2018 01/08/2020 R21 Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
PAR-18-095 See Related NICHD 11/06/2017 01/17/2018 05/08/2019 R03 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional)
PAR-18-094 See Related NICHD 11/06/2017 01/17/2018 05/08/2019 R21 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional)
PAR-18-091 See Related NICHD 11/06/2017 01/06/2018 05/08/2019 R01 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)
PA-18-096 See Related NICHD 11/06/2017 01/17/2018 05/08/2019 R21 Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)
PA-18-089 See Related NICHD 11/06/2017 01/06/2018 05/08/2019 R01 Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional)
PA-18-046 See Related NICHD 11/03/2017 01/17/2018 09/08/2019 R03 Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional)
PA-18-045 See Related NICHD 11/03/2017 01/17/2018 09/08/2019 R21 Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)
PA-18-044 See Related NICHD 11/03/2017 01/17/2018 01/08/2020 R03 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
PA-18-043 See Related NICHD 11/03/2017 01/17/2018 01/08/2020 R21 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
PA-18-038 See Related NICHD 11/03/2017 01/06/2018 01/08/2020 R01 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
PA-18-033 See Related NICHD 11/03/2017 01/06/2018 09/08/2019 R01 Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional)
PA-18-092 See Related NICHD 11/02/2017 01/17/2018 09/08/2019 R21 Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
PA-18-031 See Related NICHD 11/02/2017 01/06/2018 09/08/2019 R01 Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
PAR-18-090 See Related NICHD 11/01/2017 01/06/2018 05/08/2019 R01 Natural History of Disorders Identifiable by Screening of Newborns (R01 Clinical Trial Optional)
PAR-18-039 See Related NICHD 11/01/2017 01/06/2018 05/08/2019 R01 Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01- Clinical Trial Optional)
PAR-18-333 See Related NICHD 10/25/2017 03/04/2018 12/06/2019 R01 Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)
PAR-17-454 See Related NICHD 08/08/2017 11/06/2017 12/07/2019 R01 Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
PA-17-452 See Related NICHD 08/03/2017 09/05/2017 09/08/2020 R01 Pregnancy in Women with Disabilities (R01)
PA-17-451 See Related NICHD 08/03/2017 09/16/2017 09/08/2020 R03 Pregnancy in Women with Disabilities (R03)
PA-17-299 See Related NICHD 05/26/2017 09/16/2017 05/08/2020 R03 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
PA-17-262 See Related NICHD 04/25/2017 09/05/2017 09/08/2020 R01 Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
PAR-17-236 See Related NICHD 03/29/2017 05/05/2017 11/06/2019 R01 Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)
PAR-17-199 See Related NICHD 03/29/2017 08/05/2017 01/06/2020 R43 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)
PAR-17-200 See Related NICHD 03/29/2017 08/05/2017 01/06/2020 R41 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)
PAR-17-192 See Related NICHD 03/29/2017 05/16/2017 05/08/2020 R21 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)
PAR-17-191 See Related NICHD 03/29/2017 05/16/2017 05/08/2020 R03 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03)
PAR-17-193 See Related NICHD 03/29/2017 05/05/2017 05/08/2020 R01 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)
PAR-17-228 See Related NICHD 03/21/2017 05/19/2017 10/24/2019 R24 Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24)
PAR-17-188 See Related NICHD 03/03/2017 07/07/2017 04/04/2020 R03 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
PAR-17-169 See Related NICHD 02/21/2017 05/16/2017 05/08/2020 R21 Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
PA-17-091 See Related NICHD 12/19/2016 05/05/2017 05/08/2020 R01 Fertility Status as a Marker for Overall Health (R01)
PAR-17-005 See Related NICHD 10/07/2016 05/05/2017 11/06/2019 R01 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
PA-16-445 See Related NICHD 09/23/2016 01/05/2017 01/08/2020 R01 Trophoblast Differentiation and Function (R01)
PAR-16-366 See Related NICHD 07/12/2016 08/27/2016 09/28/2018 R01 Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01)
PAR-16-325 See Related NICHD 06/10/2016 08/19/2016 09/20/2018 R01 Biophysical and Biomechanical Aspects of Embryonic Development (R01)
PAR-16-324 See Related NICHD 06/10/2016 08/19/2016 09/20/2018 R21 Biophysical and Biomechanical Aspects of Embryonic Development (R21)
PAR-16-215 See Related NICHD 04/26/2016 05/05/2016 09/08/2019 R01 Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01)
PAR-16-149 See Related NICHD 03/23/2016 05/16/2016 05/08/2019 R03 Archiving and Documenting Child Health and Human Development Data Sets (R03)
PA-16-101 See Related NICHD 02/17/2016 05/16/2016 05/08/2019 R03 Multidisciplinary Research in Vulvodynia (R03)
PA-16-088 See Related NICHD 01/25/2016 05/05/2016 05/08/2019 R01 Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R01)
RFA-DA-19-014 See Related NIDA 09/18/2018 11/14/2018 12/15/2018 R43/R44 Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional)
RFA-DA-19-015 See Related NIDA 09/18/2018 11/14/2018 12/15/2018 R41/R42 Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 - Clinical Trial Optional)
PAR-18-918 See Related NIDA 09/10/2018 09/16/2018 09/08/2021 R03 Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
PA-18-917 See Related NIDA 09/10/2018 12/07/2018 09/08/2021 R01 Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
PA-18-916 See Related NIDA 09/10/2018 12/07/2018 09/08/2021 R03 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
PAS-18-915 See Related NIDA 09/10/2018 12/07/2018 09/08/2021 R01 HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
RFA-DA-19-009 See Related NIDA 09/07/2018 11/18/2018 12/19/2018 R01 Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
RFA-DA-19-010 See Related NIDA 09/07/2018 11/18/2018 12/19/2018 R21 Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R21-Clinical Trials Not Allowed)
PAR-18-789 See Related NIDA 05/16/2018 07/21/2018 03/20/2021 U01 Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed)
PA-18-780 See Related NIDA 05/10/2018 08/07/2018 05/08/2021 R34 Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional)
PA-18-773 See Related NIDA 05/09/2018 05/09/2018 05/08/2021 R01 International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)
PA-18-775 See Related NIDA 05/09/2018 05/16/2018 01/08/2021 R34 Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)
PA-18-774 See Related NIDA 05/09/2018 05/16/2018 05/08/2021 R34 Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
PAR-18-746 See Related NIDA 04/06/2018 05/11/2018 08/29/2020 K12 NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
PAR-18-742 See Related NIDA 04/03/2018 06/17/2018 02/12/2021 R61/R33 Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)
RFA-DA-18-022 See Related NIDA 03/14/2018 07/22/2018 08/22/2020 R01 Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
RFA-DA-19-005 See Related NIDA 03/05/2018 10/07/2018 11/08/2018 R61/R33 Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)
RFA-DA-19-003 See Related NIDA 02/15/2018 06/17/2018 07/18/2020 R61/R33 Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)
PA-18-634 See Related NIDA 02/06/2018 05/16/2018 05/08/2020 R03 NIDA Small Research Grant Program (R03 Clinical Trial Required)
PA-18-627 See Related NIDA 02/02/2018 05/25/2018 05/08/2020 R15 NIDA Academic Research Enhancement Award (R15, Clinical Trials Required)
PAS-18-624 See Related NIDA 02/02/2018 05/05/2018 09/08/2020 R01 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)
PAS-18-625 See Related NIDA 02/02/2018 05/16/2018 09/08/2020 R21 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)
PA-18-602 See Related NIDA 01/29/2018 05/16/2018 05/08/2021 R21 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional)
PA-18-601 See Related NIDA 01/29/2018 05/16/2018 05/08/2021 R03 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional)
PA-18-603 See Related NIDA 01/29/2018 05/05/2018 05/08/2021 R01 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional)
PAR-18-437 See Related NIDA 01/09/2018 07/20/2018 12/19/2020 R21 Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)
RFA-DA-18-017 See Related NIDA 12/21/2017 03/14/2018 11/16/2018 R01 Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-Clinical Trial Required)
PAR-18-527 See Related NIDA 12/18/2017 01/16/2018 05/08/2020 R03 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
PAR-18-510 See Related NIDA 12/18/2017 01/08/2018 05/08/2020 R01 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
PAR-18-509 See Related NIDA 12/18/2017 01/16/2018 05/08/2020 R21 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
PAR-18-494 See Related NIDA 12/15/2017 02/27/2018 07/25/2020 UG3/UH3 Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)
RFA-DA-19-002 See Related NIDA 12/15/2017 01/25/2018 01/02/2020 UG3/UH3 Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
RFA-DA-18-020 See Related NIDA 12/06/2017 06/25/2018 09/08/2020 UG3/UH3 NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
RFA-DA-18-019 See Related NIDA 12/06/2017 07/14/2018 08/15/2020 DP1 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
PAR-18-225 See Related NIDA 11/30/2017 08/27/2018 01/08/2020 P30 NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
PAR-18-224 See Related NIDA 11/30/2017 08/26/2018 01/08/2019 P50 NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
PAR-18-226 See Related NIDA 11/30/2017 09/18/2018 10/20/2018 DP1 Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
PAR-18-223 See Related NIDA 11/30/2017 06/17/2018 11/14/2020 R34 Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
PAR-18-222 See Related NIDA 11/30/2017 06/17/2018 11/14/2020 R01 Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
PAR-18-425 See Related NIDA 11/29/2017 12/25/2017 09/08/2019 P01 NIDA Program Project Grant Applications (P01, Clinical Trial Optional)
PAR-18-220 See Related NIDA 11/28/2017 03/25/2018 04/25/2019 U01 Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional)
PAR-18-219 See Related NIDA 11/21/2017 02/25/2018 07/26/2019 U01 Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
PAR-18-218 See Related NIDA 11/21/2017 02/25/2018 07/26/2019 R01 Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
PAR-18-086 See Related NIDA 11/17/2017 01/17/2018 09/08/2019 R21/R33 Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional)
PAR-18-085 See Related NIDA 11/17/2017 01/17/2018 09/08/2019 R33 Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional)
PAR-18-084 See Related NIDA 11/17/2017 01/17/2018 09/08/2019 R21/R33 Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)
PAR-18-082 See Related NIDA 11/17/2017 01/17/2018 01/08/2019 R03 Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
PAR-18-064 See Related NIDA 11/08/2017 01/09/2018 11/09/2018 R21 Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
PA-18-080 See Related NIDA 11/03/2017 01/17/2018 05/08/2020 R03 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional)
PA-18-079 See Related NIDA 11/03/2017 01/17/2018 05/08/2020 R21 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional)
PA-18-078 See Related NIDA 11/03/2017 01/17/2018 01/08/2020 R21 Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
PA-18-061 See Related NIDA 11/03/2017 01/06/2018 05/08/2020 R01 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional)
PA-18-060 See Related NIDA 11/03/2017 01/06/2018 01/08/2020 R01 Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
PA-18-076 See Related NIDA 11/02/2017 01/17/2018 05/08/2019 R21 Prescription Drug Abuse (R21 Clinical Trial Optional)
PA-18-074 See Related NIDA 11/02/2017 01/17/2018 01/08/2019 R03 Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional)
PA-18-073 See Related NIDA 11/02/2017 01/17/2018 01/08/2019 R34 Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
PA-18-058 See Related NIDA 11/02/2017 01/06/2018 05/08/2019 R01 Prescription Drug Abuse (R01 Clinical Trial Optional)
PA-18-055 See Related NIDA 11/02/2017 01/06/2018 01/08/2019 R01 Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
PAR-18-062 See Related NIDA 11/01/2017 01/06/2018 05/08/2019 R01 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
PA-18-057 See Related NIDA 11/01/2017 01/06/2018 05/08/2019 R01 The Application of Big Data Analytics to Drug Abuse Research (R01 Clinical Trial Optional)
RFA-DA-18-018 See Related NIDA 09/22/2017 01/01/2018 10/05/2018 R01 BRAIN Initiative: Tools to target, identify and characterize non-neuronal cells in the brain (R01 Clinical Trial Not Allowed)
PAR-17-458 See Related NIDA 08/15/2017 02/01/2018 11/01/2020 X01 Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01)
PAR-17-242 See Related NIDA 04/04/2017 07/15/2017 03/04/2020 R21 Extracellular Vesicles and Substance Use Disorders (R21)
PAR-17-250 See Related NIDA 04/04/2017 07/15/2017 03/04/2020 R01 Extracellular Vesicles and Substance Use Disorders (R01)
RFA-DA-18-004 See Related NIDA 03/31/2017 10/13/2017 11/14/2019 DP2 Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)
PA-17-157 See Related NIDA 02/08/2017 05/16/2017 05/08/2020 R21 Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
PA-17-155 See Related NIDA 02/08/2017 05/05/2017 05/08/2020 R01 Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
PA-17-119 See Related NIDA 01/10/2017 01/10/2017 01/08/2020 R01 Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
PA-17-120 See Related NIDA 01/10/2017 01/10/2017 01/08/2020 R01 Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
PA-16-443 See Related NIDA 09/22/2016 01/16/2017 01/08/2020 R36 Drug Abuse Dissertation Research (R36)
PAR-16-383 See Related NIDA 08/01/2016 09/16/2016 09/08/2019 R03 Chemistry Science Track Award for Rapid Transition (C/START) (R03)
PAR-16-384 See Related NIDA 08/01/2016 09/16/2016 09/08/2019 R21/R33 Chemical Discovery (CHEM) Award (R21/R33)
PA-16-145 See Related NIDA 03/22/2016 05/16/2016 05/08/2019 R21 Role of Astrocytes and Astrocytic Networks in Drug Abuse (R21)
PA-16-144 See Related NIDA 03/22/2016 05/05/2016 05/08/2019 R01 Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01)
RFA-DC-19-002 See Related NIDCD 07/05/2018 09/23/2018 06/25/2019 U24 Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)
RFA-DC-19-001 See Related NIDCD 07/03/2018 09/04/2018 06/05/2021 R21/R33 NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
PAR-18-700 See Related NIDCD 03/14/2018 03/15/2018 01/08/2021 F32 NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed)
PAR-18-436 See Related NIDCD 01/09/2018 01/15/2018 01/08/2021 K01 NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 - No Independent Clinical Trials)
PAR-18-435 See Related NIDCD 01/09/2018 01/15/2018 01/08/2021 K01 NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
PAR-18-562 See Related NIDCD 01/09/2018 01/10/2018 01/08/2021 K18 NIDCD Research Career Enhancement Award for Established Investigators (K18 -Clinical Trials Required)
PAR-18-564 See Related NIDCD 01/09/2018 01/10/2018 01/08/2021 K18 NIDCD Research Career Enhancement Award for Established Investigators (K18 - No Independent Clinical Trials)
PA-18-438 See Related NIDCD 01/09/2018 01/16/2018 11/06/2020 R01 Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional)
PA-18-382 See Related NIDCD 01/09/2018 01/16/2018 11/17/2020 R21 Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional)
PAR-18-556 See Related NIDCD 01/02/2018 01/05/2018 10/07/2020 P50 NIDCD Clinical Research Center Grant (P50 - Clinical Trials Optional)
PAR-18-533 See Related NIDCD 12/21/2017 05/18/2018 02/23/2021 R01 NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
PAR-18-487 See Related NIDCD 12/11/2017 01/27/2018 10/28/2020 R21 NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional)
PA-18-334 See Related NIDCD 11/13/2017 01/05/2018 01/08/2021 R01 NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required)
PAR-18-340 See Related NIDCD 11/13/2017 01/22/2018 10/22/2020 U01 NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01-Clinical Trial Required)
PA-18-343 See Related NIDCD 11/03/2017 01/25/2018 01/08/2021 R15 Academic Research Enhancement Award (R15 Clinical Trial Required)
PA-18-288 See Related NIDCD 11/02/2017 01/17/2018 05/08/2020 R21 Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)
PA-18-287 See Related NIDCD 11/02/2017 01/06/2018 05/08/2020 R01 Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional)
PA-18-328 See Related NIDCD 10/20/2017 01/16/2018 12/17/2020 R21 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21-Clinical Trial Optional)
PA-18-316 See Related NIDCD 10/20/2017 01/05/2018 12/17/2020 R01 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01-Clinical Trial Optional)
PA-18-876 See Related NIDCR 07/25/2018 09/05/2018 09/08/2021 R01 Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
PA-18-874 See Related NIDCR 07/25/2018 09/16/2018 09/08/2021 R21 Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)
PAR-18-875 See Related NIDCR 07/25/2018 09/05/2018 09/08/2021 R01 Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed)
RFA-DE-19-004 See Related NIDCR 07/11/2018 09/04/2018 10/05/2018 UG3/UH3 Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
PAR-18-788 See Related NIDCR 05/16/2018 09/16/2018 09/08/2021 R21 Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed)
PAR-18-787 See Related NIDCR 05/16/2018 09/05/2018 09/08/2021 R01 Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)
PA-18-695 See Related NIDCR 03/05/2018 04/07/2018 01/08/2021 R21 Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed)
PA-18-699 See Related NIDCR 03/05/2018 04/07/2018 01/08/2021 R01 Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed)
PAR-18-656 See Related NIDCR 02/13/2018 05/07/2018 01/08/2021 UG3/UH3 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR-18-547 See Related NIDCR 12/21/2017 01/23/2018 01/08/2021 UG3/UH3 NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required
PAR-18-432 See Related NIDCR 12/15/2017 01/12/2018 01/08/2021 K99/R00 NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)
PAR-18-360 See Related NIDCR 11/15/2017 01/12/2018 01/08/2021 K22 NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required)
PAR-18-359 See Related NIDCR 11/15/2017 01/12/2018 01/08/2021 K01 NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required)
PAR-17-154 See Related NIDCR 02/03/2017 03/14/2017 01/08/2020 U01 NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
PAR-16-409 See Related NIDCR 08/16/2016 09/16/2016 09/08/2019 R03 NIDCR Small Grant Program for New Investigators (R03)
PAR-16-362 See Related NIDCR 07/11/2016 09/16/2016 09/08/2019 R03 NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03)
PAR-16-321 See Related NIDCR 06/09/2016 09/12/2016 09/08/2019 K01 NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01)
PA-16-295 See Related NIDCR 05/27/2016 09/05/2016 09/08/2019 R01 Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01)
PA-16-296 See Related NIDCR 05/27/2016 09/16/2016 09/08/2019 R21 Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21)
PAR-16-179 See Related NIDCR 04/11/2016 05/12/2016 05/08/2019 K18 Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18)
PAR-16-156 See Related NIDCR 03/29/2016 05/12/2016 05/08/2019 K99/R00 NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 - Clinical Trial Not Allowed)
PAR-16-153 See Related NIDCR 03/25/2016 05/16/2016 05/08/2019 R21 Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R21)
PAR-16-154 See Related NIDCR 03/25/2016 05/05/2016 05/08/2019 R01 Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01)
PAR-16-140 See Related NIDCR 03/18/2016 05/12/2016 05/08/2019 K22 NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22)
PAR-16-070 See Related NIDCR 01/08/2016 01/16/2016 01/08/2019 R03 NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03)
PAR-15-344 See Related NIDCR 09/09/2015 09/16/2015 01/08/2019 R03 NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)
RFA-DK-18-501 See Related NIDDK 09/18/2018 10/20/2018 11/21/2018 U01 Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)
RFA-DK-18-502 See Related NIDDK 09/18/2018 10/20/2018 11/21/2018 U24 Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional)
PAR-18-924 See Related NIDDK 09/17/2018 10/01/2018 11/02/2019 R34 Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
PAR-18-925 See Related NIDDK 09/17/2018 10/01/2018 11/02/2019 R18 Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
RFA-DK-18-510 See Related NIDDK 09/14/2018 10/14/2018 11/15/2018 U01 Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed)
RFA-DK-18-511 See Related NIDDK 09/14/2018 10/14/2018 11/15/2018 U24 Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-DK-18-513 See Related NIDDK 09/14/2018 10/14/2018 11/15/2018 U01 Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed)
RFA-DK-18-514 See Related NIDDK 09/14/2018 10/14/2018 11/15/2018 U24 Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed)
RFA-DK-18-515 See Related NIDDK 09/14/2018 10/14/2018 11/15/2018 U24 Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed)
RFA-DK-18-017 See Related NIDDK 09/12/2018 01/21/2019 02/22/2019 R01 Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
RFA-DK-18-503 See Related NIDDK 08/30/2018 10/21/2018 11/22/2018 U01 Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
RFA-DK-18-504 See Related NIDDK 08/30/2018 10/21/2018 11/22/2018 U24 Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-DK-18-505 See Related NIDDK 08/24/2018 10/01/2018 11/01/2018 U01 Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Clinical Centers (U01 Clinical Trial Required)
RFA-DK-18-506 See Related NIDDK 08/24/2018 10/01/2018 11/01/2018 U24 Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center (U24 Clinical Trial Required)
PA-18-903 See Related NIDDK 08/14/2018 09/16/2018 09/08/2021 R21 Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional)
RFA-DK-18-011 See Related NIDDK 08/10/2018 11/11/2018 12/12/2018 UG3/UH3 Human Islet Research Network - Consortium on Human Islet Biomimetics (HIRN-CHIB) (UG3/UH3 Clinical Trial Not Allowed)
PAR-18-898 See Related NIDDK 08/09/2018 10/01/2018 06/02/2021 RC2 Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
PA-18-891 See Related NIDDK 08/07/2018 10/01/2018 06/02/2021 RC2 Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
PAR-18-886 See Related NIDDK 08/02/2018 10/01/2018 06/02/2021 RC2 New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
RFA-DK-18-012 See Related NIDDK 07/25/2018 10/08/2018 11/09/2018 U24 Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
PAR-18-857 See Related NIDDK 07/17/2018 09/16/2018 09/08/2021 R21 Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
PA-18-856 See Related NIDDK 07/17/2018 09/05/2018 09/08/2021 R01 Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
PAR-18-854 See Related NIDDK 07/12/2018 07/23/2018 09/11/2021 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
RFA-DK-18-009 See Related NIDDK 06/11/2018 02/14/2019 03/15/2019 R01 Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
RFA-DK-18-002 See Related NIDDK 05/08/2018 11/06/2018 12/07/2018 R01 Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)
PAR-18-743 See Related NIDDK 04/04/2018 05/16/2018 05/08/2021 R21 Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
PAR-18-744 See Related NIDDK 04/04/2018 05/16/2018 05/08/2021 R21 Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
RFA-DK-18-005 See Related NIDDK 04/03/2018 11/06/2018 12/07/2018 R01 Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
PA-18-741 See Related NIDDK 04/03/2018 05/16/2018 05/08/2021 R21 Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
PAR-18-727 See Related NIDDK 03/29/2018 05/11/2018 09/28/2019 R01 Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
PAS-18-730 See Related NIDDK 03/29/2018 05/05/2018 05/08/2021 R01 New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
PA-18-720 See Related NIDDK 03/27/2018 05/16/2018 05/08/2021 R21 Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
PAS-18-698 See Related NIDDK 03/05/2018 04/07/2018 01/08/2021 R01 High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
RFA-DK-17-024 See Related NIDDK 02/15/2018 03/26/2018 12/07/2018 R01 Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)
RFA-DK-17-023 See Related NIDDK 02/15/2018 03/26/2018 12/07/2018 R01 Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (R01- Clinical Trial Required)
RFA-DK-17-031 See Related NIDDK 02/15/2018 03/26/2018 12/07/2018 R01 The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
RFA-DK-17-020 See Related NIDDK 02/14/2018 04/10/2018 12/07/2018 R01 Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
RFA-DK-17-026 See Related NIDDK 02/14/2018 03/26/2018 12/07/2018 K12 Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial Optional)
PA-18-615 See Related NIDDK 02/01/2018 04/07/2018 01/08/2021 R21 Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
RFA-DK-17-018 See Related NIDDK 12/19/2017 02/20/2018 02/22/2020 R21 Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional)
PA-18-495 See Related NIDDK 12/11/2017 01/25/2018 01/08/2021 R15 Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 - Clinical Trial Required)
RFA-DK-18-001 See Related NIDDK 12/05/2017 05/01/2018 03/08/2019 P30 Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
PAR-18-111 See Related NIDDK 11/30/2017 05/02/2018 11/02/2018 RC2 High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
PAR-18-419 See Related NIDDK 11/29/2017 01/12/2018 01/08/2021 K01 NIDDK Mentored Research Scientist Development Award (K01-No Independent Clinical Trials)
PAR-18-418 See Related NIDDK 11/29/2017 01/12/2018 01/08/2021 K01 NIDDK Mentored Research Scientist Development Award (K01-Clinical Trial Required)
PAR-18-415 See Related NIDDK 11/28/2017 01/05/2018 01/08/2021 U01 NIDDK Multi-Center Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-414 See Related NIDDK 11/28/2017 01/05/2018 01/08/2021 U01 NIDDK Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
PAR-18-423 See Related NIDDK 11/28/2017 03/10/2018 11/03/2020 U34 NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
PAR-18-108 See Related NIDDK 11/28/2017 03/06/2018 09/06/2019 R44 NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
PA-18-405 See Related NIDDK 11/21/2017 01/16/2018 01/08/2021 R21 Pilot and Feasibility Therapeutic Clinical Trials in Diabetes, and Endocrine and Metabolic Diseases (R21- Clinical Trial Required)
PAR-18-105 See Related NIDDK 11/21/2017 01/29/2018 03/01/2019 R01 Ancillary Studies to Identify Behavioral and/or Psychological Phenotypes Contributing to Obesity (R01 Clinical Trial Optional)
PA-18-412 See Related NIDDK 11/17/2017 01/05/2018 01/08/2020 R01 Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
PAR-18-103 See Related NIDDK 11/17/2017 01/17/2018 05/08/2019 R03 Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03 Clinical Trial Optional)
PAR-18-102 See Related NIDDK 11/17/2017 01/17/2018 01/08/2019 R21 Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
PAR-18-051 See Related NIDDK 11/08/2017 01/06/2018 09/08/2019 R01 Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01 Clinical Trial Optional)